SBCEF-S 375MG Clinical Monograph & Batch COA
Certified DCGI Formulation Literature (PDF)
SBCEF-S 375MG
Ceftriaxone Sodium 250mg + Sulbactam 125mg Injection
SBCEF-S 375MG (Ceftriaxone Sodium 250mg + Sulbactam 125mg Injection) is manufactured under strict WHO-GMP compliance for maximum bioavailability and therapeutic efficacy.
Clinical Pharmacology & Therapeutic Profile
Comprehensive therapeutic guidelines for medical practitioners and institutional procurement
Therapeutic Indications
Mechanism of Action (MOA)
The active pharmacological principles in SBCEF-S 375MG deliver targeted therapeutic action through standardized systemic bioavailability and verified pharmacodynamics.
As directed by the registered medical practitioner. Strictly adhere to full course duration.
Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.
Store between 2°C to 8°C or below 25°C as indicated on label. Protect from light.
WHO-GMP Certified Purity
Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.
Alu-Alu Moisture Barrier
Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.
Exclusive District Monopoly
Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.
Technical Product Specifications
Active Medical Composition
SBCEF-S 375MG features Ceftriaxone Sodium 250mg + Sulbactam 125mg Injection prepared to high pharmaceutical purity standards.
*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.
Customer & Clinical Reviews
Real feedback from registered physicians, stockists, PCD franchise partners, and verified buyers.
Based on 1 verified review
Regularly stocked across our distri for SBCEF-S 375MG
SBCEF-S 375MG has been regularly stocked across our district hospital formulary, supporting swift recovery and prompt restoration of standard patient routine. The protective barrier foil preserves stability and uniform product integrity over extended shelf life. Demonstrates genuine pharmaceutical excellence with reliable supply and steady commercial pull.
Questions Regarding SBCEF-S 375MG
What is the therapeutic indication and composition of SBCEF-S 375MG?
SBCEF-S 375MG contains Ceftriaxone Sodium 250mg + Sulbactam 125mg Injection indicated for Indicated for therapeutic management within specified clinical indications under qualified physician guidance. as formulated by Sygnus Biotech.
What packaging presentations are available for SBCEF-S 375MG?
SBCEF-S 375MG is supplied in tamper-evident Single Dose Sterile Vial with Ampoule & WFI, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.
Is monopoly PCD franchise territory available for SBCEF-S 375MG?
Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for SBCEF-S 375MG along with promotional visual aids, product cards, and marketing support.
What is the regulatory schedule and minimum order quantity (MOQ)?
SBCEF-S 375MG is categorized as Schedule H1 Prescription Drug with an introductory PCD franchise MOQ of 100 units per batch.
Related Formulations in Injection
View all Injection →
SBCEF-TZ 1.125GM
Ceftriaxone Sodium 1000mg + Tazobactam 125mg